Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors

Hepatology

Volumn 30, Issue 3, 1999, Pages 665-669

  Alanen, Kenneth W ^a   Chakrabarti, Subrata ^a   Rawlins, Jenna J ^a   Howson, William ^a   Jeffrey, Gary ^a   Adams, Paul C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IRON;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; SURVIVAL;

ADOLESCENT; ADULT; AGED; CODON; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; PREVALENCE; TISSUE DONORS;

EID: 0032845303     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300308     Document Type: Article

References (23)

1. Adams PC. Population screening for hemochromatosis. HEPATOLOGY 1999;29:1324-1327.
2. Beckman LE, Saha N, Spitsyn V, Van Landeghem G, BeckmanL. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Hum Hered 1997;47:263-267.
3. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-1805.
4. Feder JN, Gnirke A, Thomas W, Tsuchihasi Z, Ruddy D, Basava A, Dormishian F, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
5. Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Hum Genet 1996;100:544-547.
6. Jazwinska EC, Cullen LM, Busfield F, Pyper W, Webb S, Powell LW, Morris CP, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-251.
7. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112: 882-888.
8. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
9. Santos M, Clevers HC, Marx JJ. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl J Med 1997;336:1327-1328.
10. Haque S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996;27:1277-1281.
11. Smith BC, Grove J, Guzail MA, Day C, Daly A, Burt A, Bassendine M. Heterozygpsity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. HEPATOLOGY 1998;27:1695-1699.
12. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl P, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-134.
13. George DK, Goldwurm S, MacDonald GA, Cowley L, Walker N, Ward P, Jazwinska E, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-318.
14. Rabinovitz M, Gavaler JS, Kelly RH, Van Thiel DH. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. HEPATOLOGY 1992;16:145-148.
15. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-1008.
16. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 1962;84:53-54.
17. Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier V. Phenotypic expression of HFE mutations: a French study of 110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999; 116:372-377.
18. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-323.
19. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med 1983;6:171-179.
20. Bassett ML, Halliday JW, Powell LW. HLA typing idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression. HEPATOLOGY 1981;1:120-126.
21. Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1998;45:146-149.
22. De Knegt RJ, Hepkema B, Slooff M, Jansen P. Hemochromatosis gene mutation in liver transplant patients [Abstract]. HEPATOLOGY 1997;26: 499A.
23. Grove J, Daly AK, Burt AD, Guzail MA, James O, Bassendine MF, Day CP. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998;43:262-266.